Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in ZyCoV D

Zydus Cadila's Coronavirus Vaccine ZyCoV-D To Be Used In 7 States Initially

ZyCov-D, which is the first COVID-19 vaccine to be cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults in the seven states as of now, sources said.

Read More

SEC Recommendations On Covaxin's Approval For 2-18 Age Group Being Examined: Govt

The CDSCO has also approved COVID-19 vaccine (ZyCoV-D) of Cadila Healthcare for restricted use in emergency situations in the age group 12 years and above

Read More

Will Offer Free Jabs To Children With 'Specified Co-Morbidities': Apollo

Zydus Cadila's Covid vaccine ZyCoV-D has already received Emergency Use Authorisation from the Drugs Controller General of India (DCGI) in the country and will be administered to those aged 12 years and above.

Read More

Cadila Healthcare Gets DCGI Nod To Conduct Phase III Trials For Two-Dose COVID Vaccine

Shares of Cadila Healthcare Ltd were trading at Rs 563.95 per scrip on BSE, up 0.29 percent from their previous close

Read More

PM Modi Hails Approval Of World’s First DNA Based ‘ZyCov-D’ Vaccine

India is fighting COVID-19 with full vigour. The approval for the world's first DNA-based ‘ZyCov-D’ vaccine of Zydus Universe is a testimony to the innovative zeal of India’s scientists. A momentous feat indeed, said PM Modi

Read More

Zydus Cadila Gets DCGI Nod For Phase-3 Clinical Trials For Covid-19 Vaccine

The Ministry said that Zydus Cadila completed Phase-I/II clinical trials of this DNA Vaccine candidate, in India, in more than 1,000 participants and interim data indicated that the vaccine is safe and immunogenic when three doses were administered intradermally.

Read More